BIOAVAILABILITY OF DISOPYRAMIDE IN NORMAL VOLUNTEERS USING UNBOUND CONCENTRATION

被引：4

作者：

BRAUN, J

SORGEL, F

GLUTH, WP

OIE, S

机构：

[1] UNIV ERLANGEN NURNBERG,CARL KORTH INST,D-8520 ERLANGEN,FED REP GER

[2] UNIV ERLANGEN NURNBERG,INST FORENS PATHOL,D-8520 ERLANGEN,FED REP GER

[3] IBMP,INST BIOMED & PHARM RES,NURNBERG,FED REP GER

[4] UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 32卷 / 06期

关键词：

D O I：

10.1007/BF02456000

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：625 / 629

页数：5

共 21 条

[1] EFFECTS OF URINE PH AND PLASMA-PROTEIN BINDING ON RENAL CLEARANCE OF DISOPYRAMIDE [J].

CUNNINGHAM, JL ;

SHEN, DD ;

SHUDO, I ;

AZARNOFF, DL .

CLINICAL PHARMACOKINETICS, 1977, 2 (05) :373-383

[2] THE EFFECT OF SATURABLE BINDING TO PLASMA-PROTEINS ON THE PHARMACOKINETIC PROPERTIES OF DISOPYRAMIDE [J].

GIACOMINI, KM ;

SWEZEY, SE ;

TURNERTAMIYASU, K ;

BLASCHKE, TF .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (01) :1-14

[3]

GIBALDI M, 1975, PHARMACOKINETICS, pCH1

[4] PHARMACOKINETICS OF ANTIARRHYTHMIC DISOPYRAMIDE IN HEALTHY HUMANS [J].

HINDERLING, PH ;

GARRETT, ER .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (03) :199-230

[5]

HUANG JD, 1983, RES COMMUN CHEM PATH, V41, P227

[6]

HUANG JD, 1984, J TAIWAN PHARM ASS, V36, P69

[7]

KABRA PM, 1981, THER DRUG MONIT, V3, P91

[8] CLINICAL PHARMACOKINETICS OF DISOPYRAMIDE [J].

KARIM, A ;

NISSEN, C ;

AZARNOFF, DL .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (05) :465-494

[9] NOVEL METHOD FOR BIOAVAILABILITY ASSESSMENT [J].

KWAN, KC ;

TILL, AE .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (09) :1494-1497

[10] DISOPYRAMIDE PHARMACOKINETICS AND BIOAVAILABILITY FOLLOWING THE SIMULTANEOUS ADMINISTRATION OF DISOPYRAMIDE AND C-14-DISOPYRAMIDE [J].

LIMA, JJ ;

HAUGHEY, DB ;

LEIER, CV .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (03) :289-313

← 1 2 3 →